Paraoxonase
US5629193A · kind A · utility
8Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 1994 |
| Grant date | May 13, 1997 |
| Priority date | — |
| Expiry date | Jul 5, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Human paraoxonase enzyme and DNA (RNA) encoding such paraoxonase enzymes are disclosed. Also provided is the procedure for producing such polypeptides by recombinant techniques. Uses of such polypeptides include their use as an antidote for organophosphate poisoning and to prevent neuronal cell death.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.